Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women
- PMID: 30765035
- PMCID: PMC6383781
- DOI: 10.1016/j.jacc.2018.11.040
Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women
Abstract
Background: Currently as many as one-half of women with suspected myocardial ischemia have no obstructive coronary artery disease (CAD), and abnormal coronary reactivity (CR) is commonly found.
Objectives: The authors prospectively investigated CR and longer-term adverse cardiovascular outcomes in women with and with no obstructive CAD in the National Heart, Lung, and Blood Institute-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Methods: Women (n = 224) with signs and symptoms of ischemia underwent CR testing. Coronary flow reserve and coronary blood flow were obtained to test microvascular function, whereas epicardial CR was tested by coronary dilation response to intracoronary (IC) acetylcholine and IC nitroglycerin. All-cause mortality, major adverse cardiovascular events (MACE) (cardiovascular death, myocardial infarction, stroke, and heart failure), and angina hospitalizations served as clinical outcomes over a median follow-up of 9.7 years.
Results: The authors identified 129 events during the follow-up period. Low coronary flow reserve was a predictor of increased MACE rate (hazard ratio [HR]: 1.06; 95% confidence interval [CI]: 1.01 to 1.12; p = 0.021), whereas low coronary blood flow was associated with increased risk of mortality (HR: 1.12; 95% CI: 1.01 to 1.24; p = 0.038) and MACE (HR: 1.11; 95% CI: 1.03 to 1.20; p = 0.006) after adjusting for cardiovascular risk factors. In addition, a decrease in cross-sectional area in response to IC acetylcholine was associated with higher hazard of angina hospitalization (HR: 1.05; 95% CI: 1.02 to 1.07; p < 0.0001). There was no association between epicardial IC-nitroglycerin dilation and outcomes.
Conclusions: On longer-term follow-up, impaired microvascular function predicts adverse cardiovascular outcomes in women with signs and symptoms of ischemia. Evaluation of CR abnormality can identify those at higher risk of adverse outcomes in the absence of significant CAD. (Women's Ischemia Syndrome Evaluation [WISE]; NCT00000554).
Keywords: cardiovascular outcome; coronary flow reserve; coronary reactivity; endothelial function; microvasculature.
Copyright © 2019 American College of Cardiology Foundation. All rights reserved.
Figures





Comment in
-
The Feminine Face of Ischemic Heart Disease: Challenges and Opportunities.J Am Coll Cardiol. 2019 Feb 19;73(6):694-697. doi: 10.1016/j.jacc.2018.12.011. J Am Coll Cardiol. 2019. PMID: 30765036 No abstract available.
References
-
- Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101:1899–906. - PubMed
-
- Jespersen L, Hvelplund A, Abildstrom SZ et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J 2012;33:734–44. - PubMed
-
- Johnson BD, Shaw LJ, Pepine CJ et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women’s Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J 2006;27:1408–15. - PubMed
-
- Pepine CJ, Anderson RD, Sharaf BL et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study. J Am Coll Cardiol 2010;55:2825–32. - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- N01 HV068161/HV/NHLBI NIH HHS/United States
- U01 HL064829/HL/NHLBI NIH HHS/United States
- N01 HV068163/HL/NHLBI NIH HHS/United States
- T32 HL007745/HL/NHLBI NIH HHS/United States
- R03 AG032631/AG/NIA NIH HHS/United States
- T32 HL069751/HL/NHLBI NIH HHS/United States
- P30 DK079626/DK/NIDDK NIH HHS/United States
- UL1 TR000124/TR/NCATS NIH HHS/United States
- UL1 TR001427/TR/NCATS NIH HHS/United States
- N01 HV068164/HV/NHLBI NIH HHS/United States
- M01 RR000425/RR/NCRR NIH HHS/United States
- N01 HV068162/HL/NHLBI NIH HHS/United States
- K23 HL105787/HL/NHLBI NIH HHS/United States
- UL1 TR001881/TR/NCATS NIH HHS/United States
- R01 HL090957/HL/NHLBI NIH HHS/United States
- N01 HV068163/HV/NHLBI NIH HHS/United States
- N01 HV068162/HV/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous